3924-0015 Screening compound: N-{5-[(3E)-6-bromo-2-oxo-2,3-dihydro-1H-indol-3-ylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl}-4-hydroxy-3-methoxybenzamide

3924-0015 Screening compound: N-{5-[(3E)-6-bromo-2-oxo-2,3-dihydro-1H-indol-3-ylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl}-4-hydroxy-3-methoxybenzamide
3924-0015 Screening compound: N-{5-[(3E)-6-bromo-2-oxo-2,3-dihydro-1H-indol-3-ylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl}-4-hydroxy-3-methoxybenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 3924-0015
N-{5-[(3E)-6-bromo-2-oxo-2,3-dihydro-1H-indol-3-ylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl}-4-hydroxy-3-methoxybenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

3924-0015

Molecular Formula

C19H12BrN3O5S2 (C19 H12 BrN3 O5 S2)

Compound Name

N-{5-[(3E)-6-bromo-2-oxo-2,3-dihydro-1H-indol-3-ylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl}-4-hydroxy-3-methoxybenzamide

IUPAC name

N-{5-[(3E)-6-bromo-2-oxo-23-dihydro-1H-indol-3-ylidene]-4-oxo-2-sulfanylidene-13-thiazolidin-3-yl}-4-hydroxy-3-methoxybenzamide

SMILES

COc(cc(cc1)C(NN(C(/C(/S2)=C(/c(ccc(Br)c3)c3N3)\C3=O)=O)C2=S)=O)c1O

InChI

InChI=1S/C19H12BrN3O5S2/c1-28-13-6-8(2-5-12(13)24)16(25)22-23-18(27)15(30-19(23)29)14-10-4-3-9(20)7-11(10)21-17(14)26/h2-7,24H,1H3,(H,21,26)(H,22,25)

InChI Key

UQNWKUFWMYEWIJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD02077635

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

506.36

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.326

Distribution Coefficient, logD

2.273

Water Solubility, LogSw

-3.03

Polar Surface Area

92.266

Acid Dissociation Constant (pKa)

8.28

Base Dissociation Constant (pKb)

-0.78

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

5.30

3924-0015 in Drug Discovery

Included in Screening Libraries

DGK Inhibitors Library (10558 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Carbonic Anhydrase II Library (4939 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with 3924-0015 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 3924-0015?
Check Price and Availability of 3924-0015, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 3924-0015 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 3924-0015
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 3924-0015
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 3924-0015 available by request